Virchows Archiv

, Volume 443, Issue 1, pp 44–50

Pregnancy and breast cancer: a population-based study

  • W. Reed
  • E. Hannisdal
  • E. Skovlund
  • S. Thoresen
  • P. Lilleng
  • J. M. Nesland
Original Article

DOI: 10.1007/s00428-003-0817-z

Cite this article as:
Reed, W., Hannisdal, E., Skovlund, E. et al. Virchows Arch (2003) 443: 44. doi:10.1007/s00428-003-0817-z

Abstract

The incidence of pregnancy-associated breast cancer, i.e. during pregnancy and lactation, and of pregnancy subsequent to a breast-cancer diagnosis will increase as more women choose childbearing at a later age. Few larger series are published on pregnancy-associated breast cancer. In a population-based study, we evaluated the outcome and prognostic factors in 173 breast-cancer patients. One hundred and twenty-two patients had pregnancy-associated breast cancer (20 coincident with pregnancy and 102 during lactation) and 51 patients had pregnancy subsequent to breast cancer. The median follow-up time was 151 months. Histopathological parameters and immunoreactivity for oestrogen and progesterone receptors c-erbB-2 and c-erbB-4 were studied. All three groups had tumours with high histological grade, low frequency of hormone receptors and high expression of c-erbB-2. The pregnancy and lactation groups were near identical with regard to all histopathological parameters and outcome. In the two pregnancy-associated breast-cancer groups, tumours were significantly larger, with more extensive lymph-node involvement. For node-negative tumours the respective 5- and 10-year survival rates were 62% and 50% in the pregnancy group and 60% and 50% in the lactation group. For node-positive tumours, respective 5- and 10-year survival rates were 50% and 34% in the pregnancy group and 50% and 33% in the lactation group. In the subsequent group, overall survival was high in both node-negative and -positive groups, with 5- and 10-year survival rates of 80% and 73% and 86% and 76%, respectively. Tumour size, lymph-node status, histological grade, progesterone receptor, oestrogen receptor and c-erbB-2 were significant prognostic factors in the pregnancy-associated breast-cancer patients.

Keywords

Pregnancy Breast cancer Hormone receptor c-erbB-2 c-erbB-4 Prognostic factors 

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • W. Reed
    • 1
  • E. Hannisdal
    • 2
  • E. Skovlund
    • 3
  • S. Thoresen
    • 4
  • P. Lilleng
    • 5
  • J. M. Nesland
    • 1
  1. 1.Department of PathologyThe Norwegian Radium Hospital, University of OsloOsloNorway
  2. 2.Health NorthBodøNorway
  3. 3.Section of Medical StatisticsUniversity of OsloNorway
  4. 4.The Norwegian Cancer RegistryOsloNorway
  5. 5.Institute of GadeHaukeland HospitalBergenNorway

Personalised recommendations